Sio Gene Therapies Inc. Profile Avatar - Palmy Investing

Sio Gene Therapies Inc.

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize …

Biotechnology
US, New York [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SIOX's Analysis
CIK: 1636050 CUSIP: 829399104 ISIN: US8293991043 LEI: - UEI: -
Secondary Listings
SIOX has no secondary listings inside our databases.